Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now

NCT03728348 is registered in ClinicalTrials.gov with Exact Sciences Corporation as lead sponsor.

NCT NCT03728348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03728348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Lead sponsor
Exact Sciences Corporation
Phase
Observational
Overall status
Completed
Start date
November 6, 2018
Completion date
June 18, 2019
Enrollment
983 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer